Design of 3‐Phenylcoumarins and 3‐Thienylcoumarins as Potent Xanthine Oxidase Inhibitors: Synthesis, Biological Evaluation, and Docking Studies
ChemMedChem · 2023
DOI: 10.1002/cmdc.202300400 ↗Kurz gefasst
Fachartikel in der Zeitschrift ChemMedChem, 2023. Verfasst von Antonella Fais und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Life and Environmental Sciences, University of Cagliari, S.P. 8 km 0.700, 09042, Cagliari, Italy. Hauptthemen laut MEDLINE: Xanthine Oxidase, Enzyme Inhibitors. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministerio de Ciencia e Innovación.
Abstract (Originalsprache)
Coumarin scaffold has proven to be promising in the development of bioactive agents, such as xanthine oxidase (XO) inhibitors. Novel hydroxylated 3‐arylcoumarins were designed, synthesized, and evaluated for their XO inhibition and antioxidant properties. 3‐(3’‐Bromophenyl)‐5,7‐dihydroxycoumarin (compound 11 ) proved to be the most potent XO inhibitor, with an IC 50 of 91 nM, being 162 times better than allopurinol, one of the reference controls. Kinetic analysis of compound 11 and compound 5 [3‐(4’‐bromothien‐2’‐yl)‐5,7‐dihydroxycoumarin], the second‐best compound within the series (IC 50 of 280 nM), has been performed, and both compounds showed a mixed‐type inhibition. Both compounds present good antioxidant activity (ability to scavenge ABTS radical) and are able to reduce reactive oxygen species (ROS) levels in H 2 O 2 ‐treated cells. In addition, they proved to be non‐cytotoxic in a Caco‐2 cells viability assay. Molecular docking studies have been carried out to correlate the compounds’ theoretical and experimental binding affinity to the XO binding pocket.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Life and Environmental Sciences, University of Cagliari, S.P. 8 km 0.700, 09042, Cagliari, Italy.
- Department of Electrical and Electronic Engineering, University of Cagliari, Via Marengo 2, 09123, Cagliari, Italy.
- Translational Health Science and Technology Institute, NCR Biotech Science Cluster, Faridabad, 121001, India.
- Department of Biomedical Sciences, University of Cagliari, S.P. 8 km 0.700, 09042, Monserrato, Italy.
- Departamento de Química Orgánica, Facultade de Farmacia, Universidade Santiago de Compostela, 15782, Santiago de Compostela, Spain.
- Instituto de Ciencias Químicas Aplicadas, Universidad Autónoma de Chile, 7500912, Santiago, Chile.
ORCID-Profile: Sonia Floris, Maria João Matos
Förderung
- Ministerio de Ciencia e Innovación
Zitieren
APA
Fais, A., Pintus, F., Era, B., Floris, S., Kumar, A., Sarmadhikari, D., Sogos, V., Uriarte, E., Asthana, S., & Matos, M. J. (2023). Design of 3‐Phenylcoumarins and 3‐Thienylcoumarins as Potent Xanthine Oxidase Inhibitors: Synthesis, Biological Evaluation, and Docking Studies. ChemMedChem. https://doi.org/10.1002/cmdc.202300400
Vancouver
Fais A, Pintus F, Era B, Floris S, Kumar A, Sarmadhikari D, et al. Design of 3‐Phenylcoumarins and 3‐Thienylcoumarins as Potent Xanthine Oxidase Inhibitors: Synthesis, Biological Evaluation, and Docking Studies. ChemMedChem. 2023. doi:10.1002/cmdc.202300400
BibTeX
@article{Fais2023,
author = {Fais, Antonella and Pintus, Francesca and Era, Benedetta and Floris, Sonia and Kumar, Amit and Sarmadhikari, Debapriyo and Sogos, Valeria and Uriarte, Eugenio and Asthana, Shailendra and Matos, Maria João},
title = {Design of 3‐Phenylcoumarins and 3‐Thienylcoumarins as Potent Xanthine Oxidase Inhibitors: Synthesis, Biological Evaluation, and Docking Studies},
journal = {ChemMedChem},
year = {2023},
doi = {10.1002/cmdc.202300400}
}
EUVIMED